BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.2% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Vanguard Information Technology ETF
VGT
$149B
| $33.9K | ﹤0.01% |
1,352
| – | – |
|
|
INWK
3602
DELISTED
InnerWorkings, Inc.
INWK
| $33.7K | ﹤0.01% |
9,320
+5,209
| +127% | +$23.3K |
|
3603
Twin Disc
TWIN
$355M
| $33.6K | ﹤0.01% |
2,020
+1,734
| +606% | +$29.6K |
|
|
ESXB
3604
DELISTED
Community Bankers Trust Corporation
ESXB
| $33.3K | ﹤0.01% |
4,552
+3,839
| +538% | +$29.5K |
|
3605
LCNB Corp
LCNB
$281M
| $33.2K | ﹤0.01% |
1,936
+1,609
| +492% | +$26.7K |
|
3606
Northeast Bank
NBN
$1.15B
| $33.1K | ﹤0.01% |
1,603
+1,411
| +735% | +$27.8K |
|
|
ADMS
3607
DELISTED
Adamas Pharmaceuticals
ADMS
| $33.1K | ﹤0.01% |
+4,657
| New | +$41.9K |
|
|
PVTL
3608
DELISTED
Pivotal Software, Inc.
PVTL
| $33K | ﹤0.01% |
1,585
+1,049
| +196% | +$20.5K |
|
|
LOVE
3609
LoveSac
LOVE
$253M
| $33K | ﹤0.01% |
1,187
+1,100
| +1,264% | +$29.8K |
|
3610
Oil-Dri
ODC
$1.28B
| $33K | ﹤0.01% |
2,120
+1,782
| +527% | +$25.3K |
|
3611
Chemung Financial Corp
CHMG
$401M
| $33K | ﹤0.01% |
703
+610
| +656% | +$27.1K |
|
|
SNV
3612
DELISTED
Synovus
SNV
| $33K | ﹤0.01% |
960
-152,967
| -99% | -$5.61M |
|
3613
Lineage Cell Therapeutics
LCTX
$278M
| $33K | ﹤0.01% |
25,171
+21,080
| +515% | +$26.2K |
|
3614
Acacia Research
ACTG
$455M
| $32.9K | ﹤0.01% |
10,107
+7,446
| +280% | +$23.1K |
|
3615
NI Holdings
NODK
$314M
| $32.9K | ﹤0.01% |
2,059
+1,727
| +520% | +$26.7K |
|
3616
Magna International
MGA
$18.6B
| $32.9K | ﹤0.01% |
676
-2,079
| -75% | -$105K |
|
|
XELA
3617
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $32.9K | ﹤0.01% |
+1
| New | +$46K |
|
3618
Riverview Bancorp
RVSB
$106M
| $32.9K | ﹤0.01% |
4,498
+3,750
| +501% | +$28.3K |
|
|
SBBX
3619
DELISTED
SB One Bancorp Common Stock
SBBX
| $32.9K | ﹤0.01% |
1,513
+1,267
| +515% | +$27.8K |
|
3620
United States Lime & Minerals
USLM
$3.42B
| $32.8K | ﹤0.01% |
2,125
+1,845
| +659% | +$26.6K |
|
3621
GrafTech
EAF
$201M
| $32.8K | ﹤0.01% |
256
+14
| +6% | +$1.86K |
|
3622
Suburban Propane Partners
SPH
$1.18B
| $32.7K | ﹤0.01% |
1,460
-240
| -14% | -$5.3K |
|
3623
Harvard Bioscience
HBIO
$28.1M
| $32.6K | ﹤0.01% |
757
+654
| +635% | +$23.7K |
|
3624
Bausch Health
BHC
$2.32B
| $32.6K | ﹤0.01% |
1,318
+575
| +77% | +$13.7K |
|
3625
Spyre Therapeutics
SYRE
$9.18B
| $32.5K | ﹤0.01% |
+161
| New | +$33.6K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.